Helping to Research Potential Migraine Treatments

Clinical trials are a great way to help contribute to our understanding of migraine in children and teens, and research potential treatments. Listen to Tresor and Sophie's stories of their experience participating in a clinical trial.

Biohaven Pharmaceuticals is studying an investigational drug to potentially treat migraines in children and teens. If your child is between 6 and 17 years of age and has at least a 6-month history of migraine, they may qualify. Learn more about our pediatric migraine study.